Released in September 2006, this volume from the National Academy of Sciences summarizes "the current status of health effects in veterans deployed to the Persian Gulf irrespective of exposure information." In layman's terms, the volume is primarily concerned with reviewing, evaluating, and summarizing the scientific and medical literature which addresses the current health status of Gulf War...

Released yesterday by the Department of Defense (DOD) Special Assistant for Gulf War Illnesses and the RAND Corporation, a 385-page report concluded that the drug Pyridostigmine Bromide, or "PB," could not be ruled out as a possible cause for some of the illnesses veterans of the Gulf War have reported. The Office of the Special Assistant for Gulf War Illnesses site contains a message from the...

Released yesterday by the Department of Defense (DOD) Special Assistant for Gulf War Illnesses and the RAND Corporation, this 385-page report concluded that the drug Pyridostigmine Bromide, or "PB," could not be ruled out as a possible cause for some of the illnesses veterans of the Gulf War have reported. PB was given to approximately 250,000 US troops sent to the Persian Gulf between 1990 and...